Author:
Gómez-Martín Carlos,Concha Ángel,Corominas José María,García-Caballero Tomás,García-García Elena,Iglesias Mar,López José Antonio,Ramón y Cajal Santiago,Rojo Federico,Palacios José,Vera-Sempere Francisco,Aranda Enrique,Colomer Ramon,García-Alfonso Pilar,Garrido Pilar,Rivera Fernando,López-Ríos Fernando
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference41 articles.
1. Bang YJ, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastrooesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697
2. Allison M (2010) The HER2 testing conundrum. Nat Biotechnol 28:117–119
3. Yamamoto T, Ikawa S, Akiyama T et al (1986) Similarity of protein encoded by the human cerb-B-2 gene to epidermal growth factor receptor. Nature 319:230–234
4. Cortés-Funes H, Rivera F, Alés I et al (2007) Phase II of trastuzumab and cisplatin in patients (pts) with advanced gastric cancer (AGC) with HER2/neu overexpression/amplification. J Clin Oncol 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement): 4613
5. Hofmann M, Stoss O, Shi D et al (2008) Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology 52: 797–805
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献